NCT00189176View on ClinicalTrials.gov

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Tetrathiomolybdate

Trial Locations (1)

48109

University of Michigan Health System, Ann Arbor

All Listed Sponsors
collaborator

Coalition for Pulmonary Fibrosis

UNKNOWN

lead

University of Michigan

OTHER

NCT00189176 - Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter